Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Modelling viral infections using zebrafish: innate immune response and antiviral research

  • Varela, Mónica
  • Figueras Huerta, Antonio
  • Novoa, Beatriz
10 pages, 1 figure, 2 tables, Zebrafish possess a highly developed immune system that is remarkably similar to the human one. Therefore, it is expected that the majority of the signalling pathways and molecules involved in the immune response of mammals exist and behave similarly in fish. The innate antiviral response depends on the recognition of viral components by host cells. Pattern recognition receptors initiate antimicrobial defence mechanisms via several well-conserved signalling pathways. In this paper, we review current knowledge of the antiviral innate immune response in zebrafish by considering the main molecules that have been characterized and the infection models used for the in vivo study of the antiviral innate immune response. We next summarize published studies in which larval and adult zebrafish were used to study viral diseases of fish, then provide a similar review of studies of human viral diseases in zebrafish and experience with antiviral drug screening in this model organism., This work was funded by the projects CSD2007-00002 “Aquagenomics” and AGL2014-51773-C3 from the Spanish Ministerio de Economía y Competitividad. M. Varela received a predoctoral personal grant from the JAE Program (funded through the CSIC and European Social Funds)., Peer reviewed
Dipòsit Digital de Documents de la UAB
Publication Artículo de revisión (ReviewArticle)

Review : Hydroxychloroquine and chloroquine for treatment of SARS-CoV-2 (COVID-19)

  • Pastick, Katelyn A.
  • Okafor, Elizabeth C.
  • Wang, Fan
  • Lofgren, Sarah M.
  • Skipper, Caleb P.
  • Nicol, Melanie R.
  • Pullen, Matthew F.
  • Rajasingham, Radha
  • McDonald, Emily G.
  • Lee, Todd C.
  • Schwartz, Ilan S.
  • Kelly, Lauren E.
  • Lother, Sylvain A.
  • Mitjà, Oriol|||0000-0003-3266-8868
  • Letang, Emili
  • Abassi, Mahsa
  • Boulware, David R.
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a rapidly emerging viral infection causing coronavirus disease 2019 (COVID-19). Hydroxychloroquine and chloroquine have garnered unprecedented attention as potential therapeutic agents against COVID-19 following several small clinical trials, uncontrolled case series, and public figure endorsements. While there is a growing body of scientific data, there is also concern for harm, particularly QTc prolongation and cardiac arrhythmias. Here, we perform a rapid narrative review and discuss the strengths and limitations of existing in vitro and clinical studies. We call for additional randomized controlled trial evidence prior to the widespread incorporation of hydroxychloroquine and chloroquine into national and international treatment guidelines.